Therefore, it is reasonable to make the deduction that tumor cell response to CDDP-based chemotherapy might be overcome by targeting the KEAP1/NRF2-mediated disturbance of ferroptosis, as presented and verified in this study. This evidence concerns the gene NFE2L2 and neoplasm.